alexa Increasing Of Alive Plague Vaccine Efficiency | 20583
ISSN: 2157-7560

Journal of Vaccines & Vaccination
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

4th International Conference on Vaccines & Vaccination
September 24-26, 2014 Valencia Convention Centre, Spain

Ponomaryova T S, Deryabin P N, Atshabar B B, Tugambaev T I, Melnikova N N, Karalnik B V, Denisova T G and Zakaryan S B
Posters: J Vaccines Vaccin
DOI: 10.4172/2157-7560.S1.021
Abstract
P lague is the infection No 1 in the world. The natural foci of plague occupy about 40% of the territory of Kazakhstan. In the CIS, including Kazakhstan and Russia, alive plague vaccine from Yersinia pestis EV strains (APV) is used for vaccinations against plague. However, its application requires annual revaccination. Being active enough for primary vaccination, it is much less effective at revaccinations. We developed two approaches to increase given vaccine efficiency. The first is connected with increased vaccine?s immunogenicity within the process of its production. For this purpose stock culture suspension was administrated to a rabbit intravenously at stage of vaccine operational seed lot production and further extracted from this rabbit inner organs culture was used for further stages of vaccine production. Such procedure named animalization resulted not only in confident (p<0.05) increase (up to 1.8-fold) of alive cells quantity of finished balk-vaccine, but also increased immunogenetic (protective) activity: Significant (p<0.01) increased survival rates of guinea pigs (2.2 -fold) and reduced ED50 up to 9.5-fold with confidence (p<0.05). The second approach to increase effectiveness of APV is connected with immunomodulation. In modeling studies with infected guinea pigs it is shown that co- administration of APV and an immunomodulator (Polyoxidonium with recombinant interleukin-1 β) increases protective activity of the vaccine (p<0.01) and significantly reduces mortality rates among animal models. In addition, effect of immunomodulation on antigen - spe-cific immune response indicators was studied in the studies where rabbits were immunized with APV with and without immunomodulators. It is shown that these preparations accelerate devel-opment of specific antigenetic response to APV at both early, and effector phase. Calculation of used immunization schemes efficiency integrated rate demonstrated better result for recombinant interleukin -1 β. Results of our studies demonstrated effectiveness of the described approaches to increase APV efficiency and the need for further research of immunomodulation, including dur-ing vaccinations of humans.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version